Alzheimer’s drug from Eli Lilly wins backing of FDA committee
Washington Post
An advisory committee to the Food and Drug Administration found the drug was safe and effective at slowing the progression of the disease, setting the stage for the agency to approve it.
https://www.washingtonpost.com/business/2024/06/10/alzheimers-drug-fda-eli-lilly/